Floatz logo

HUMAN FAECAL MATTER

Multiple Sclerosis

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sother_biologicalPhase 2Active
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
65/ 100

Competitive context

182 Active assets in the Multiple Sclerosis cohort.

Asset / SponsorPhaseRating
Fampridine
MGH Institute of Health Professions
Phase 4BBB
Cladribine
University Hospital, Strasbourg, France
Phase 4BBB
Teriflunomide
Sanofi
Phase 4BBB
Ocrevus
Polpharma Biologics International AG
Phase 4BBB
Nabiximols
Jazz Pharmaceuticals
Phase 4BBB

View all 50 →

Same molecule, other indications

HUMAN FAECAL MATTER is also rated in:

cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
hepatic encephalopathyDormant
B
Indicative ·
61 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →